To determine the level of CD5 among T cell subsets and within peripheral organs and tumor cells, mice subcutaneously implanted with syngeneic triple-negative 4T1 breast tumors were euthanized on day 21 after implantation and spleen, lymph nodes, and tumor tissue were harvested and processed to generate single cell suspensions containing immune cells. Here, CD5 is linked to neoplasm.